Avidity Partners Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Avidity Partners Management’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,136	Closed	-$1.94K	–	96
2024 Q2	$1.94K	Sell	12,136 -77,407	-86%	-$15.8K	﹤0.01%	85
2024 Q1	$27.1K	Hold	89,543	–	–	﹤0.01%	90
2023 Q4	$5.37K	Hold	89,543	–	–	﹤0.01%	74
2023 Q3	$8.95K	Sell	89,543 -1,017	-1%	-$136	﹤0.01%	83
2023 Q2	$15K	Sell	90,560 -9,439	-9%	-$1.47K	﹤0.01%	93
2023 Q1	$12K	Hold	99,999	–	–	﹤0.01%	83
2022 Q4	$14.4K	Hold	99,999	–	–	﹤0.01%	84
2022 Q3	$18K	Hold	99,999	–	–	﹤0.01%	96
2022 Q2	$28K	Hold	99,999	–	–	﹤0.01%	81
2022 Q1	$76K	Hold	99,999	–	–	﹤0.01%	91
2021 Q4	$189K	Hold	99,999	–	–	﹤0.01%	96
2021 Q3	$253K	Hold	99,999	–	–	0.01%	103
2021 Q2	$260K	Hold	99,999	–	–	0.01%	111
2021 Q1	$267K	Buy	+99,999	New	+$289K	0.01%	94

Other funds holding NUVB.WS

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

GCM

Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Avidity Partners Management's NUVB.WS Position: Q3 2024 in Review

Avidity Partners Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q3 2024, closing a stake of 12,136 shares — an estimated $1.94K sold.

Avidity Partners Management first reported a position in NUVB.WS in Q1 2021 and held it in 14 quarters. The position peaked at $267K in Q1 2021. 21 funds tracked by Wall St. Rank hold NUVB.WS as of Q3 2024.

Avidity Partners Management reported no remaining Nuvation Bio Inc Warrants position as of Q3 2024 after selling out during the quarter.
Avidity Partners Management sold 12,136 Nuvation Bio Inc Warrants shares in Q3 2024, an estimated $1.94K.
Avidity Partners Management first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 14 quarters.
Avidity Partners Management's Nuvation Bio Inc Warrants position peaked at $267K in Q1 2021.
21 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q3 2024.

Based on Avidity Partners Management's 13F filing for Q3 2024, filed 14 Nov 2024.